高分辨率断连组预测基底动脉闭塞取栓结局与反应
本研究为法国多中心前瞻性卒中登记的事后分析,纳入2017至2024年连续基底动脉闭塞且入院行磁共振的患者,通过弥散加权成像将梗死灶投射至健康人超高分辨率弥散MRI构建的后颅窝优化纤维束图,估算断连纤维体积。结果显示断连纤维体积预测90天改良Rankin量表0-3 vs 4-6的AUC为0.84,优于NIHSS、梗死体积和pc-ASPECTS,且在NIHSS≤10患者中仍最强。
要点
- 断连纤维体积预测基底动脉闭塞90天不良结局AUC 0.84,优于NIHSS等传统指标。
- 无显著断连者全量表结局更佳(OR 0.12),且从成功再通中获益更大(OR 0.33)。
- NIHSS≤10患者中断连纤维体积仍为最强预测因子(AUC 0.83)。
核心结论
- 间接推导的断连纤维体积是基底动脉闭塞结局的稳健预后标志物,优于传统预测因子,可能支持未来治疗决策,但需前瞻性验证。
研究设计与样本
- 法国多中心前瞻性卒中登记的事后分析,纳入2017-2024年连续基底动脉闭塞且入院行磁共振的患者201例,中位年龄70岁,中位NIHSS 10分。
- 以2名健康参与者超高分辨率弥散MRI构建后颅窝优化的规范性纤维束图,将患者DWI梗死灶投射估算断连纤维体积。
主要发现
- 201例中97例(48.3%)结局不良;中位梗死体积仅4.75 mL,但断连纤维体积中位达25.15 mL。
- 断连纤维体积预测90天mRS 0-3 vs 4-6的AUC为0.84,优于NIHSS(0.67,P<0.0001)、梗死体积(0.75,P=0.00059)和pc-ASPECTS(0.76,P=0.0127)。
- 无显著断连者全mRS谱结局更佳(OR 0.12,95%CI 0.065-0.204),且从成功再通中获益更大(OR 0.33,95%CI 0.15-0.70)。
- NIHSS≤10亚组(n=102)中断连纤维体积仍为最强预测因子(AUC 0.83)。
临床怎么用
- 对基底动脉闭塞患者,可基于入院DWI估算断连纤维体积辅助预后判断,尤其NIHSS≤10的轻症患者。
- 无显著断连者可能从成功再通中获益更大,但该结论尚需前瞻性验证后方可用于治疗决策。
局限性
- 为登记研究的事后分析,断连纤维体积的预后价值需前瞻性验证后方可支持治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute basilar artery occlusion causes devastating strokes. Despite the benefit of endovascular treatment, the optimal management remains controversial in specific subgroups, particularly patients with mild deficits, and would benefit from robust prognostic tools. Given the dense white matter networks within the posterior fossa, we tested whether quantifying disconnections from acute diffusion-weighted imaging could improve outcome prediction and identify responders to recanalization compared with conventional metrics. METHODS: We conducted a secondary analysis of a prospective multicenter stroke registry in France, including consecutive patients (2017-2024) with basilar artery occlusion and admission magnetic resonance imaging. Ultra-high-resolution diffusion magnetic resonance imaging was acquired in 2 healthy participants to build normative tractograms with optimized posterior fossa quality. Patient infarcts delineated on diffusion-weighted imaging were projected onto these tractograms to estimate disconnected fiber volume. The primary outcome was 90-day modified Rankin Scale score (0-3 versus 4-6). Predictive performance of disconnected fiber volume was compared with baseline National Institutes of Health Stroke Scale (NIHSS), infarct volume, and posterior circulation Alberta Stroke Program Early Computed Tomography Score using logistic regressions and area under the receiver operating characteristic curves. Ordinal regressions tested associations between dichotomized disconnection status and the full modified Rankin Scale spectrum, stratified by recanalization status. Analyses were repeated in patients with an NIHSS score ≤10. RESULTS: Among 201 patients (median age, 70; NIHSS score, 10), 97 (48.3%) had a poor outcome. Despite a small median infarct volume (4.75 mL), disconnected fiber volume was substantial (median 25.15 mL). Disconnected fiber volume achieved an area under the receiver operating characteristic curves of 0.84, outperforming NIHSS score (0.67; P<0.0001), infarct volume (0.75; P=0.00059), and posterior circulation Alberta Stroke Program Early Computed Tomography Score (0.76; P=0.0127). Patients without significant disconnection had better outcomes across the full modified Rankin Scale spectrum (odds ratio, 0.12 [95% CI, 0.065-0.204]) and derived greater benefit from successful recanalization (odds ratio, 0.33 [95% CI, 0.15-0.70]). In patients with an NIHSS score ≤10 (n=102), disconnected fiber volume remained the strongest predictor (area under the receiver operating characteristic curves of 0.83). CONCLUSIONS: Disconnected fiber volume derived indirectly is a robust prognostic marker of basilar artery occlusion outcomes that outperforms conventional predictors and may support future treatment decisions after prospective validation. REGISTRATION: URL: https://clinicaltrials.gov; Unique identifier: NCT03776877.
引用
- Authamayou B, Marnat G, Matsulevits A, et al. High-Resolution Disconnectome Predicts Outcome and Response to Thrombectomy in Basilar Artery Occlusion. Stroke. 2026. PMID: 42723634. doi:10.1161/STROKEAHA.126.056382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。